Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07153016 · ClinicalTrials.gov registry record · NA

LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorectal Cancer

A NA study of Colorectal Cancer and Caregiver Burden, sponsored by Masonic Cancer Center, University of Minnesota.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT07153016: Recruiting NA study of Colorectal Cancer and Caregiver Burden, sponsored by Masonic Cancer Center, University of Minnesota.

NCT07153016 is a NA study of Colorectal Cancer and Caregiver Burden that is actively recruiting participants, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 20 participants, below the 1,545-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07153016, a NA study of Colorectal Cancer and Caregiver Burden, is actively recruiting participants, sponsored by Masonic Cancer Center, University of Minnesota.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This is a single center single-arm, pilot study of proactive and early connection with free legal care services for patient-caregiver dyads affected by colorectal cancer to assess the feasibility, acceptability, and preliminary efficacy of this intervention in improving financial and psychosocial outcomes. Participants (i.e. patient-caregiver dyads) will receive free, personalized legal care services from Cancer Legal Care (CLC), a nonprofit organization located in the Twin Cities of Minnesota. The duration of study participation is 3 months, however, participants may continue to access free personalized legal care services beyond this period.

Primary Outcome

Feasibility will be measured through rates of 1) initial engagement (i.e., percent of patients and caregivers who meet with a CLC representative), 2) continued engagement (i.e., percentage of patients and caregivers who respond to questionnaires at months 3), and 3) intervention completion (i.e., percentage of patients and caregivers who receive a legal service). The mean of the 3 metrics will be used to determine feasibility. The intervention will be deemed as feasible if ≥50% is met on each of

Interventions

  • OTHER Legal Services

Study Locations (1)

Minnesota

  • Masonic Cancer Center - Minneapolis

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-09-09
Est. Completion 2027-12-31
Phase NA

What NCT07153016 shows while recruiting

NCT07153016 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,545-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Legal Services is the first listed.

NCT07153016 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT07153016 about?

NCT07153016 is a clinical study titled "LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorectal Cancer". This is a single center single-arm, pilot study of proactive and early connection with free legal care services for patient-caregiver dyads affected by colorectal cancer to assess the feasibility, acceptability, and preliminary efficacy of this intervention in improving financial and psychosocial ou...

What is the current status of trial NCT07153016?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-09-09. Estimated completion is 2027-12-31.

What conditions does trial NCT07153016 study?

This clinical trial studies the following conditions: Colorectal Cancer, Caregiver Burden, Legal Intervention.

What interventions are being tested in trial NCT07153016?

The interventions under investigation include: Legal Services (OTHER).

Who is sponsoring clinical trial NCT07153016?

This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07153016 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07153016's enrollment target sits among peer trials

20 346th of 381 higher than 33 of 381 other Colorectal Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07153016, the US trial registry maintained by the National Library of Medicine. NCT07153016 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.